ORCIPRENALINE SULFATE — all Canadian products
8 DINs
1 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is ORCIPRENALINE SULFATE, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02236565 | ORCIPRENALINE | APOTEX INC | Syrup | Oral | ORCIPRENALINE SULFATE 2 MG | Approved | |
| 00003859 | ALUPENT LIQ 50MG/ML | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | Liquid | Inhalation; Oral | ORCIPRENALINE SULFATE 50 MG | Cancelled Post Market | |
| 00249920 | ALUPENT SYR 10MG/5.0ML | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | Syrup | Oral | ORCIPRENALINE SULFATE 10 MG | Cancelled Post Market | |
| 00003891 | ALUPENT TAB 20MG | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | Tablet | Oral | ORCIPRENALINE SULFATE 20 MG | Cancelled Post Market | |
| 02229862 | ORCIPREN | TECHNILAB PHARMA INC. | Syrup | Oral | ORCIPRENALINE SULFATE 10 MG | Cancelled Post Market | |
| 02236783 | ORCIPRENALINE | AA PHARMA INC | Syrup | Oral | ORCIPRENALINE SULFATE 2 MG | Dormant | |
| 02152568 | RATIO-ORCIPRENALINE SYRUP 2MG/ML | RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | Syrup | Oral | ORCIPRENALINE SULFATE 2 MG | Cancelled Post Market | |
| 02192675 | TANTA ORCIPRENALINE SYRUP - SYR 2MG/ML | TANTA PHARMACEUTICALS INC | Syrup | Oral | ORCIPRENALINE SULFATE 2 MG | Cancelled Post Market |
Browse other molecules: